March 2007
MSI Newsletter
Volume 2 - Issue 3
 

New Interactive Features on the MSI Website

Landmark Studies & Ongoing Trials
 

Click here to view all studies and trials

View information on current landmark studies and ongoing trials for:

  • Therapeutic lifestyle changes, obesity management
  • Hypoglycaemic agents
  • Lipid-modifying agents
  • Antihypertensive agents
  • Others
International Guidelines
 

Click here to view all guidelines

View international guidelines on cardiovascular disease, diabetes, nutrition, hypertension and lipids

 
Featured Abstracts


Click here to view all recent news

Chronic work stress linked to general and central obesity

StressIn the so-called Whitehall II population-based study including 6895 men and 3413 women aged 35-55 years, self-reported cumulative work stress was measured on 4 occasions over a 19-year period using the Job Strain Questionnaire to investigate the link between chronic work stress and obesity.
> more

Dietary energy density as an independent predictor of obesity, elevated fasting insulin, and metabolic syndrome in US adults

VegetablesFiber content, energy density and/or water content affect the satietogenic properties of foods. High-density palatable foods are potentially associated with lesser satiety and/or increased daily caloric intake. A cross-sectional study using representative data of US adults aged =20 years from the National Health and Nutrition Examination Survey (n=9688) was conducted to assess whether dietary energy density of foods was associated with obesity and related disorders including insulin resistance and metabolic syndrome (NECP-ATP III criteria).
> more

Dramatic increase in the prevalence of the metabolic syndrome in Finnish young adults

FinlandIn a longitudinal population-based follow-up study of 2182 healthy Finnish young adults aged 24-39 years, the current prevalence of the metabolic syndrome according to the definitions of the National Cholesterol Education Program (NCEP), the European Group for the Study of Insulin Resistance (EGIR) and the International Diabetes Federation (IDF) was 13.0%, 9.8% and 14.3%, respectively.
> more

 
Upcoming Congresses
 
Date:
  February 28-March 3, 2007
Location:
  Buena Vista Palace
Orlando, Florida
Website:
  http://www.americanheart.org/presenter.jhtml?identifier=3038389
The 55th Annual Scientific Session, ACC
Date:
  March 24-27, 2007
Location:
  New Orleans, Louisiana
USA
Website:
  http://www.acc07.acc.org
Keystone Symposia - Metabolic Syndrome and Cardiovascular Risk
Date:
  March 27 - April 1, 2007
Location:
  Steamboat Springs, Colorado
Website:
  http://www.keystonesymposia.org
American Association of Clinical Endocrinologists
Date:
  April 11-15, 2007
Location:
  Seattle, Washington
Website:
  http://www.aace.com/meetings/ams/2007/index.php
15th European Congress on Obesity
Date:
  April 22-25, 2007
Location:
  Budapest, Hungary
Website:
  http://www.eco2007.org
2nd International Congress on "Prediabetes and Metabolic Syndrome"
Epidemiology, Management and Prevention of Diabetes and Cardiovascular Disease
Date:
  April 25-28, 2007
Location:
  Barcelona, Spain
Website:
  http://www.kenes.com/prediabetes
XXI InterAmerican Congress of Cardiology
Date:
  April 26-29, 2007
Location:
  Lima, Peru
Website:
  http://www.siicsalud.com/dato/dat050/06828012.htm
 
2007 - Metabolic Syndrome Institute Awards
Application deadline:
June 1, 2007
 
"Fighting the Metabolic Syndrome:
Original Contributions"
Objective:
 
To promote new talents and research themes around the MetS concept
Definition:
 
Three awards per year
Applicants:
 
Young researchers / clinicians
Topics:
 
Any original contributions to the fight against MetS
Resources:
  Jury: the Scientific Committee of the Metabolic Syndrome Institute
Reward:
  $10,000 (USD) per award
Output:
 

- Manuscripts for peer-reviewed journals with MSI grant mentioned in acknowledgements
- Communication campaign: MSI website, press releases, press conferences

Application file:
 

Download application

Rules & Regulations:
  Download rules & regulations

Cardiovascular Risk Calculators

Framingham Risk Assessment Tool
Estimates 10-year risk of developing hard CHD

Procam Risk Calculator
Estimates your risk of a heart attack (myocardial infarction) within the next 10 years based upon data of the PROCAM Study

SCORE (European High Risk Chart)
Estimates 10 year risk of fatal CVD in high risk regions of Europe by gender, age, systolic blood pressure, total cholesterol and smoking status.

UKPDS Risk Engine
The UKPDS Risk Engine is a type 2 diabetes specific risk calculator based on 53,000 patients years of data from the UK Prospective Diabetes Study , which also provides an approximate 'margin of error' for each estimate.

 
Mission of the Metabolic
Syndrome Institute

Created in 2003, the Metabolic Syndrome Institute is an independent and not for profit association. Its members are international experts in lipid metabolism, diabetes, heart disease, endocrinology obesity, genetics, epidemiology, basic research and health economics. Being the first association totally devoted to the dissemination of knowledge about the metabolic syndrome, the Metabolic Syndrome Institute will provide an international multidisciplinary approach to a worldwide public health problem.

 
Contact Metabolic Syndrome Institute
15, rue du Marquis de Coriolis
92563 Rueil-Malmaison Cedex
FRANCE
Tel: 33 1 41 42 20 35
Fax: 33 1 41 42 20 01
Email:

contact@metabolic-syndrome-institute.org
Website:
http://www.metabolic- syndrome-institute.org

 

Coordinated by Dr. Scott Grundy, President of the IAS